vs
Epsilon Energy Ltd.（EPSN）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Epsilon Energy Ltd.的1.3倍（$19.6M vs $14.8M），Epsilon Energy Ltd.净利率更高（-83.9% vs -177.4%，领先93.5%），Epsilon Energy Ltd.同比增速更快（65.7% vs -11.5%），过去两年Epsilon Energy Ltd.的营收复合增速更高（36.2% vs -12.2%）
εpsilon复合材料公司是一家法国企业，由现任首席执行官斯特凡纳·勒尔于1987年1月创立，生产基地位于法国加扬，专注复合材料相关业务经营。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
EPSN vs LAB — 直观对比
营收规模更大
LAB
是对方的1.3倍
$14.8M
营收增速更快
EPSN
高出77.2%
-11.5%
净利率更高
EPSN
高出93.5%
-177.4%
两年增速更快
EPSN
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.8M | $19.6M |
| 净利润 | $-12.4M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | -129.0% | -168.5% |
| 净利率 | -83.9% | -177.4% |
| 营收同比 | 65.7% | -11.5% |
| 净利润同比 | -1535.0% | -28.8% |
| 每股收益（稀释后） | $-0.55 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPSNLAB
| Q4 25 | $14.8M | — | ||
| Q3 25 | $9.0M | $19.6M | ||
| Q2 25 | $11.6M | $21.8M | ||
| Q1 25 | $16.2M | $40.8M | ||
| Q4 24 | $8.9M | — | ||
| Q3 24 | $7.3M | $22.1M | ||
| Q2 24 | $7.3M | $22.5M | ||
| Q1 24 | $8.0M | $45.5M |
净利润EPSNLAB
| Q4 25 | $-12.4M | — | ||
| Q3 25 | $1.1M | $-34.7M | ||
| Q2 25 | $1.6M | $-33.5M | ||
| Q1 25 | $4.0M | $-26.0M | ||
| Q4 24 | $-760.8K | — | ||
| Q3 24 | $366.0K | $-26.9M | ||
| Q2 24 | $815.7K | $-45.7M | ||
| Q1 24 | $1.5M | $-32.2M |
毛利率EPSNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率EPSNLAB
| Q4 25 | -129.0% | — | ||
| Q3 25 | 6.7% | -168.5% | ||
| Q2 25 | 7.1% | -118.1% | ||
| Q1 25 | 44.3% | -80.8% | ||
| Q4 24 | 6.8% | — | ||
| Q3 24 | 3.3% | -120.9% | ||
| Q2 24 | 16.0% | -134.5% | ||
| Q1 24 | 17.6% | -132.2% |
净利率EPSNLAB
| Q4 25 | -83.9% | — | ||
| Q3 25 | 11.9% | -177.4% | ||
| Q2 25 | 13.3% | -153.7% | ||
| Q1 25 | 24.8% | -63.8% | ||
| Q4 24 | -8.5% | — | ||
| Q3 24 | 5.0% | -122.0% | ||
| Q2 24 | 11.2% | -203.3% | ||
| Q1 24 | 18.9% | -70.6% |
每股收益（稀释后）EPSNLAB
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $0.05 | $-0.09 | ||
| Q2 25 | $0.07 | $-0.09 | ||
| Q1 25 | $0.18 | $-0.07 | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $0.02 | $-0.07 | ||
| Q2 24 | $0.04 | $-0.12 | ||
| Q1 24 | $0.07 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.0M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $124.7M | $399.7M |
| 总资产 | $228.2M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EPSNLAB
| Q4 25 | $9.0M | — | ||
| Q3 25 | $12.8M | $129.4M | ||
| Q2 25 | $9.9M | $158.6M | ||
| Q1 25 | $6.9M | $150.9M | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $8.3M | $210.6M | ||
| Q2 24 | $8.6M | $269.8M | ||
| Q1 24 | $2.3M | $287.1M |
总债务EPSNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益EPSNLAB
| Q4 25 | $124.7M | — | ||
| Q3 25 | $100.2M | $399.7M | ||
| Q2 25 | $100.2M | $424.5M | ||
| Q1 25 | $99.7M | $454.6M | ||
| Q4 24 | $96.7M | — | ||
| Q3 24 | $98.4M | $489.3M | ||
| Q2 24 | $99.6M | $510.3M | ||
| Q1 24 | $99.9M | $577.3M |
总资产EPSNLAB
| Q4 25 | $228.2M | — | ||
| Q3 25 | $126.3M | $539.6M | ||
| Q2 25 | $123.6M | $557.0M | ||
| Q1 25 | $125.5M | $579.6M | ||
| Q4 24 | $120.5M | — | ||
| Q3 24 | $121.8M | $681.5M | ||
| Q2 24 | $121.1M | $708.7M | ||
| Q1 24 | $125.1M | $777.7M |
负债/权益比EPSNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-277.0K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流EPSNLAB
| Q4 25 | $-277.0K | — | ||
| Q3 25 | $4.0M | $-22.2M | ||
| Q2 25 | $8.3M | $-20.7M | ||
| Q1 25 | $8.6M | $-30.3M | ||
| Q4 24 | $5.0M | — | ||
| Q3 24 | $2.7M | $-27.9M | ||
| Q2 24 | $5.4M | $-39.0M | ||
| Q1 24 | $3.7M | $-62.5M |
自由现金流EPSNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率EPSNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度EPSNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
现金转化率EPSNLAB
| Q4 25 | — | — | ||
| Q3 25 | 3.70× | — | ||
| Q2 25 | 5.38× | — | ||
| Q1 25 | 2.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.50× | — | ||
| Q2 24 | 6.60× | — | ||
| Q1 24 | 2.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPSN
| Gas Oil Ngls And Condensate | $13.3M | 90% |
| Gas Gathering And Compression | $1.5M | 10% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
